Analyzing each factor separately, it was found that LC3B expression decreased with time since TNBS administration (ANOVA, p < 0.001; Figure S5A), as well as a significant reduction in its expression, was caused by the induction of colitis (ANOVA, p < 0.01; Figure S5C). The gene discussed is MAP1LC3B; the disease is colitis.